News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Morningside Venture Investments Ltd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 29,048 shares
@ $30.45, valued at
$884.5k
|
|
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 34,641 shares
@ $31.69, valued at
$1.1M
Sold 28,807 shares
@ $32.17, valued at
$926.7k
|
|
| 03/17/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 9,122 shares
@ $32.55, valued at
$296.9k
|
|
| 03/16/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 70,714 shares
@ $34.54, valued at
$2.4M
Sold 108,934 shares
@ $33.12, valued at
$3.6M
Sold 41,066 shares
@ $33.68, valued at
$1.4M
|
|
| 03/06/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $33.75, valued at
$1.7M
|
|
| 02/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Sold 39,916 shares
@ $35.91, valued at
$1.4M
Sold 10,084 shares
@ $36.34, valued at
$366.5k
Sold 48,889 shares
@ $35.55, valued at
$1.7M
Sold 1,111 shares
@ $36.24, valued at
$40.3k
|
|
| 02/07/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.146, valued at
$178.7k
Sold 40,000 shares
@ $6.883, valued at
$275.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 50,000 shares
@ $6.85, valued at
$342.5k
|
|
| 01/25/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 80,000 shares
@ $6.81, valued at
$544.8k
Sold 80,000 shares
@ $6.98, valued at
$558.4k
|
|
| 01/19/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 6,114 shares
@ $6.79, valued at
$41.5k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/09/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 12,162 shares
@ $6.97, valued at
$84.8k
Sold 3,000 shares
@ $6.89, valued at
$20.7k
|
|
| 01/05/2023 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 25,000 shares
@ $7.1, valued at
$177.5k
Sold 500 shares
@ $7.1, valued at
$3.6k
Sold 30,000 shares
@ $7.17, valued at
$215.1k
|
|
| 10/05/2022 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Sold 28,700 shares
@ $8.779, valued at
$252k
Sold 3,612 shares
@ $8.8199, valued at
$31.9k
|
|
| 08/15/2022 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on GreenLight Biosciences Holdings, PBC|
Txns:
| Bought 3,061,224 shares
@ $3.92, valued at
$12M
|
|
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2022 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Amylyx Pharmaceuticals, Inc.|
Txns:
| Converted 10,415,650 shares
@ $0
Bought 263,158 shares
@ $19, valued at
$5M
Converted 1,409,035 preferred shares
@ $0
Converted 6,410,964 preferred shares
@ $0
Converted 974,107 preferred shares
@ $0
Converted 1,621,544 preferred shares
@ $0 |
|
| 11/18/2021 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 250,000 shares
@ $40, valued at
$10M
|
|
| 02/06/2020 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 3,800,000 shares
@ $2.6, valued at
$9.9M
|
|
| 01/21/2020 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 540,540 shares
@ $37, valued at
$20M
|
|
| 03/13/2019 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 441,176 shares
@ $17, valued at
$7.5M
|
|
| 09/24/2018 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 19,599 shares
@ $18.79, valued at
$368.3k
Bought 21,724 shares
@ $19.43, valued at
$422.1k
Bought 40,000 shares
@ $19.84, valued at
$793.6k
|
|
| 09/19/2018 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Bought 31,400 shares
@ $18.5, valued at
$580.9k
Bought 8,600 shares
@ $18.84, valued at
$162k
Bought 40,000 shares
@ $18.47, valued at
$738.8k
Bought 60,000 shares
@ $18.09, valued at
$1.1M
|
|
| 08/01/2018 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Converted 442,819 shares
@ $0
Converted 109,909 shares
@ $0
Converted 3,420,516 preferred shares
@ $0
Converted 1,849,490 preferred shares
@ $0
Disposed of 319,664 options to buy
@ $0.01, valued at
$3.2k
Acquired 18,996 options to buy
@ $0.01, valued at
$190 |
|
| 06/27/2018 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Converted 1,051,630 shares
@ $0
Converted 1,007,422 shares
@ $0
Bought 250,000 shares
@ $15, valued at
$3.8M
Converted 1,051,630 convertible preferred
@ $0
Converted 1,007,422 convertible preferred
@ $0 |
|
| 11/13/2017 |
4
| Morningside Venture Investments Ltd (10% Owner) has filed a Form 4 on Apellis Pharmaceuticals, Inc.|
Txns:
| Converted 10,778,303 shares
@ $0
Bought 575,000 shares
@ $14, valued at
$8.1M
Converted 1,054,544 preferred shares
@ $0
Converted 17,200,000 preferred shares
@ $0
Converted 4,476,275 preferred shares
@ $0
Converted 259,302 preferred shares
@ $0 |
|
|
|